The spectrum of TP53 mutations in Rwandan patients with gastric cancer.

"Declarations Ethics approval and consent to participateThe study was approved by the institutional Review Board (IRB) of the University of Rwanda College of Medicine and Health Sciences (Approval notice N° 295/CMHSIRB/2020 and N° 310/CMHSIRB/2021), the Ethical Committee of the University Teaching Hospital of Kigali (Ref.: EC/CHUK/2/064/2020) and the ethics committee of the Hamamatsu University School of Medicine (EC HUSM number: 20 − 011). All study participants were informed of the purpose of the study and voluntarily signed an informed consent form before participating in this study. Competing interestsThe authors declare that they have no competing interests. Competing interests The authors declare that they have no competing interests."

"Funding This research was funded by the Japan Society for the Promotion of Science (20K07445) (KS), Smoking Research Foundation (HS) and HUSM Grant-in-Aid (HS)."